|
Market Closed -
Nasdaq
16:00:00 2026-09-21 EDT
|
5-day change | 1st Jan Change | ||
| 3.225 USD | +0.16% |
|
-6.25% | -5.43% |
| 08-06 | B. Riley Adjusts Price Target on LifeMD to $8 From $10, Maintains Buy Rating | MT |
| 08-05 | LifeMD, Inc., Q2 2026 Earnings Call, Aug 05, 2026 |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Healthcare Industry Software | ||||||||||
Telehealth | 68.2M | 82.65M | 98.15M | 158M | 194M | |||||
Total Assets | 48.06M | 18.16M | 48.13M | 62.34M | 70.41M | |||||
Interest Expense | - | - | - | -2.18M | -1.36M | |||||
EBT | - | - | - | -18.96M | -10.19M | |||||
Gross Profit | - | - | - | 137M | - | |||||
Operating Income | -51.41M | -45.92M | -25.26M | -16.79M | -7.67M | |||||
| - | - | - | - | 194M | ||||||
Office and Home Productivity Software | ||||||||||
Worksimpli | 24.68M | 36.38M | 54.39M | 54.02M | - | |||||
Total Assets | 1.87M | 7.5M | 10.35M | 10.12M | - | |||||
Interest Expense | - | - | - | -6.41K | - | |||||
EBT | - | - | - | 636K | - | |||||
Gross Profit | - | - | - | 51.39M | - | |||||
Operating Income | -2.89M | 2.47M | 10.77M | 643K | - | |||||
Beauty Care Products | ||||||||||
Online Direct Marketing Business | - | - | - | - | - | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
Eliminations | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Vitamins and Nutritional Supplements | ||||||||||
Nutraceutical and Cosmetic Additives | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
International | - | - | - | 14.9M | - | |||||
United States | 92.88M | 119M | 153M | 198M | - | |||||
Total Assets | 49.92M | 25.67M | 58.48M | - | - | |||||
Interest Expense | -3.02M | -1.28M | -2.6M | - | - | |||||
Income Tax Expense | 7.7K | 361K | 428K | - | - | |||||
D&A | 356K | 1.09M | 1.18M | - | - | |||||
CAPEX | -3.4M | -12.89M | -204K | - | - | |||||
Gross Profit | 74.88M | 100M | 134M | - | - | |||||
Net Income | -60.9M | -45.54M | -20.6M | - | - | |||||
EBT | -61.32M | -44.66M | -17.41M | - | - | |||||
Operating Income | -54.3M | -43.45M | -14.49M | - | - |
- Stock Market
- Stocks
- LFMD Stock
- Financials LifeMD, Inc.
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
















